Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The LabelBenzinga • 04/21/21
Bellwether J&J Squashes First-Quarter Views; Will Other Medical Stocks Follow?Investors Business Daily • 04/20/21
Johnson & Johnson (JNJ) CEO Alex Gorsky on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/20/21
Johnson & Johnson jumps as vaccine shipments to Europe set to resume after regulator says benefits outweigh blood clot risks (JNJ, DJIA, INX)Business Insider • 04/20/21
Johnson & Johnson vaccine ‘pause' isn't crimping confidence in the vaccination process, survey saysMarket Watch • 04/20/21
J&J to resume COVID-19 vaccine shipments to EU, with a warning 'very rare' adverse eventsMarket Watch • 04/20/21
Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) ReviewPRNewsWire • 04/20/21
EU Warns Of 'Possible Link' Between Johnson & Johnson Vaccine And Blood Clots—But Says Benefits Still Outweigh RisksForbes • 04/20/21
Johnson & Johnson COVID-19 vaccine has possible link to very rare cases of unusual blood clots, says EU regulatorProactive Investors • 04/20/21
EU agency finds possible blood clot link with J&J vaccine but says benefits outweigh risksCNBC • 04/20/21